Various studies indicate that C-reactive protein (CRP) could act as a biomarker for the diagnosis of hepatitis B virus (HBV)-related HCC in patients who test negative for alpha-fetoprotein (AFP) (She et al., 2015). Here, CRP is linked to hepatocellular carcinoma.